LIGAND PHARMACEUTICALS INCORPORATED
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2012 | $-369.0K | $-388.0K | $19.0K | $709.0K |
| Jun 2012 | $-732.0K | $-974.0K | $242.0K | — |
| Sep 2012 | $-910.0K | $-1.3M | $372.0K | — |
| Mar 2013 | $2.1M | $2.0M | $37.0K | $1.1M |
| Jun 2013 | $6.9M | $6.8M | $121.0K | — |
| Sep 2013 | $-359.0K | $-464.0K | $105.0K | — |
| Mar 2014 | $2.6M | $2.6M | $6.0K | $2.1M |
| Jun 2014 | $4.0M | $4.0M | $-6.0K | — |
| Sep 2014 | $3.7M | $3.7M | $0 | — |
| Mar 2015 | $7.6M | $7.6M | $10.0K | $2.9M |
| Jun 2015 | $10.0M | $10.0M | $17.0K | — |
| Sep 2015 | $10.4M | $10.4M | $0 | — |
| Mar 2016 | $13.1M | $12.9M | $238.0K | $4.1M |
| Jun 2016 | $10.4M | $9.6M | $783.0K | — |
| Sep 2016 | $18.5M | $17.8M | $762.0K | — |
| Mar 2017 | $19.2M | $19.1M | $87.0K | $6.0M |
| Jun 2017 | $10.4M | $10.3M | $112.0K | — |
| Sep 2017 | $27.7M | $27.6M | $21.0K | — |
| Mar 2018 | $60.8M | $60.8M | — | $4.6M |
| Jun 2018 | $73.6M | $73.6M | — | — |
| Sep 2018 | $27.1M | $27.1M | — | — |
| Mar 2019 | $45.3M | $45.3M | — | $5.3M |
| Jun 2019 | $-61.1M | $-61.1M | — | — |
| Sep 2019 | $-6.2M | $-6.2M | — | — |
| Mar 2020 | $16.9M | $16.9M | — | $5.7M |
| Jun 2020 | $24.4M | $24.4M | — | — |
| Sep 2020 | $12.7M | $12.7M | — | — |
| Mar 2021 | $10.8M | $7.4M | $3.4M | $8.4M |
| Jun 2021 | $20.4M | $19.0M | $1.4M | — |
| Sep 2021 | $20.0M | $18.3M | $1.8M | — |
| Mar 2022 | $52.0M | $47.1M | $4.9M | $9.0M |
| Jun 2022 | $11.9M | $5.3M | $6.6M | — |
| Sep 2022 | $20.5M | $16.2M | $4.3M | — |
| Mar 2023 | $33.9M | $31.5M | $2.4M | $5.9M |
| Jun 2023 | $-82.0K | $-285.0K | $203.0K | — |
| Sep 2023 | $7.6M | $7.2M | $487.0K | — |
| Mar 2024 | $18.7M | $18.6M | $105.0K | $7.3M |
| Jun 2024 | $13.3M | $12.9M | $408.0K | — |
| Sep 2024 | $36.5M | $35.9M | $596.0K | — |
| Mar 2025 | $-25.4M | $-25.7M | $214.0K | $7.8M |
| Jun 2025 | $15.8M | $15.6M | $214.0K | — |
| Sep 2025 | $13.1M | $13.1M | $15.0K | — |
| Mar 2026 | $48.7M | $48.5M | $228.0K | $10.6M |
| Jun 2026 | $24.0M | $24.0M | $26.0K | — |